Market data
Medical Conditions Disorders
Explore verified medical conditions disorders statistics and market research reports with sourced data and trend analysis.
Latest update:
Elif Demirci
Aids Statistics
Antiretroviral therapy is changing the curve faster than most people expect, with 2025 and 2026 data showing how prevention and treatment gains are reshaping outcomes. Read these AIDS statistics to see the exact contrasts between progress and the gaps that still leave too many people unprotected.
Cancer Survivorship Statistics
Cancer Survivorship is more than a diagnosis timeline, it is a set of measurable outcomes that keep changing as care improves. See how the latest numbers in 2025 and 2026 reflect shifting survival and ongoing care needs, so you can understand what progress really looks like after treatment.
Childhood Diabetes Statistics
About 5% of U.S. children and adolescents ages 2 to 19 live with diabetes or prediabetes, but the real shock is how fast risk can turn into emergencies, with 3.3% experiencing DKA at type 1 diagnosis. This page pairs big-picture prevalence with sharply measurable day-to-day realities like A1C gaps, severe hypoglycemia rates, and CGM gains so you can see exactly where childhood diabetes care is working and where it still falls short.
Endometrial Cancer Survival Statistics
Find out how survival outcomes for endometrial cancer have shifted into 2025, with numbers that can feel surprisingly different from what many patients expect. This page breaks down the statistics that matter most so you can compare likely outcomes with clearer context and make sense of what the timeline actually means.
Spinal Injury Statistics
Every year, 17,000 people in the UK are diagnosed with a spinal cord injury, yet the most urgent gains come from decisions made fast, such as decompression within 24 hours and early rehabilitation within 72 hours that can shift outcomes dramatically. This page also puts a hard price tag on care and complications, with lifetime costs estimated at $3.1 million per person and indirect economic losses running into thousands more, alongside practical prevention and treatment evidence for issues like pressure ulcers and neurogenic bladder.
Heart Attack Survival Rate Statistics
See how every minute counts, from a 7 to 10% survival hit for each 1-minute delay in defibrillation after collapse to 35.1% survival to discharge when public-access defibrillation is in play. Then compare heart attack pathways and system performance, including 6.7% in-hospital mortality for NSTEMI and the shift from worse outcomes with slower reperfusion to better survival with timely PCI and bystander CPR that more than doubles the odds of making it to discharge.
Blood Cancer Statistics
With blood cancer incidence and survival figures updated through 2025, you get a sharper picture of how quickly outcomes can change from diagnosis to treatment. The page pairs the most recent burden statistics with survival contrasts across types, so you see what is improving and what is still not.
Mouth Cancer Statistics
Mouth cancer rates and survival details keep shifting, and the latest 2025 and 2026 figures make clear who is still falling through the cracks. Read these mouth specific statistics to see the gap between risk and outcome and what it means for prevention and early detection.
Cancer Deaths Statistics
Cancer deaths remain a massive global burden projected to worsen significantly.
Squamous Cell Carcinoma Statistics
Why some squamous cell cancers spread and others stay localized often comes down to risk factors like immunosuppression, perineural invasion, and poor differentiation, and the outcomes can swing dramatically from about 86% 5 year relative survival for localized vulvar SCC to about 54% for regional disease. This page ties those prognosis drivers to the latest treatment and burden contrasts including 2.3 million U.S. skin cancer cases each year and a 47% objective response rate for cemiplimab in advanced cutaneous SCC.
Men With Breast Cancer Statistics
Men With Breast Cancer statistics reveal a stark mismatch between how rarely the public hears about it and how real the numbers are, with 2026 estimates placing cases higher than most people expect. If you are wondering whether your risk can be overlooked, the latest figures on incidence, diagnosis patterns, and outcomes make the case impossible to dismiss.
Mononucleosis Statistics
Mononucleosis still surprises clinicians and families with how often it spreads through close contact and how frequently the typical recovery timeline runs long enough to disrupt school and work. The latest statistics quantify that gap, including the groups most at risk and the real strain it puts on health systems in 2025.
Fas Statistics
Fas statistics cut through the noise by showing exactly how fast things are changing, including the sharp 2025 shift in key metrics. If you only track the headline averages, you will miss what the details reveal about where performance is actually moving.
Global Cardiovascular Disease Statistics
In 2025, cardiovascular disease remains the leading cause of death, claiming 18.6 million lives worldwide while 47.2% of deaths come from heart and stroke conditions. The page puts that scale in sharp relief by mapping how many people are living with coronary heart disease, stroke, and high blood pressure and what that means for prevention beyond the headlines.
Female Hemophilia Statistics
Women with hemophilia face a higher cardiovascular risk and a heavy day to day burden, with 1.4 to 1.6 times the hazard of ischemic heart disease and 70% reporting at least one joint bleed every year, yet care delays and underdiagnosis can keep many from getting the right prophylaxis early. This page also highlights why bleeding control matters beyond symptoms, including 60% needing medical attention in the prior 12 months and quality of life gains tied to lower annualized bleeding rates, alongside inhibitor and hepatitis B prevalence that shape long term outcomes.
Mrsa Statistics
MRSA remains a stubborn threat, and the latest figures for 2025 show just how quickly it can still reshape hospital risk. This page connects the year’s most important rates to what they mean for infection control right now.
Stroke Statistics
Stroke is a global emergency on a scale that surprises even clinicians, with GBD 2019 estimating 143.2 million DALYs worldwide and US Medicare spending running in the tens of billions each year. This page connects those stakes to practical impact and care gaps, from thrombectomy results like 71.1% functional independence in EXTEND-IA and 60.2% in SWIFT PRIME to real world treatment patterns such as IV alteplase reaching 6.8% of acute ischemic patients in GWTG-Stroke and the often several hour median arrival after symptom onset.
Non--Small Cell Lung Cancer Statistics
Lung cancer is poised to be 22% of all cancer deaths in 2024, while real world NSCLC biology is increasingly test driven, with KRAS G12C appearing in about 13% of cases and broad NGS use rising to 56% for advanced patients. Track how PD L1 and targeted therapies translate into outcomes and costs, from CheckMate 017 and PACIFIC survival gains to the $30,000 to $50,000 range for a pembrolizumab course and multiplex NGS pricing around $2,500 per patient.
Autism Race Statistics
Autism Race statistics show how dramatically outcomes can shift when you measure progress with the right lens, including 2026 figures that put fresh numbers on participation, support, and results. See what stands out when the usual story changes and which signals matter most for families and advocates.
Placental Abruption Statistics
Placental abruption affects about 0.3% of pregnancies overall yet is tied to major outcomes, including roughly 24,000 US stillbirths each year from placental disorders. You will see how often it starts with bleeding, how coagulopathy and hypertensive disorders cluster with it, and what current evidence reports about imaging and biomarkers such as ultrasound sensitivity near 25% and D dimer elevation in 85%.